Drug & intervention
atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution [Phenohytro]
RxCUI 2048015
What this record represents
SBDF · RxNormThis is an RxNorm SBDF drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
PhenohytroBN · CureCurrent ID 62514
atropine / hyoscyamine / phenobarbital / scopolamine Oral Tablet [Phenohytro]SBDF · CureCurrent ID 62516
atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG [Phenohytro]SBDC · CureCurrent ID 62515
atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet [Phenohytro]SBD · CureCurrent ID 62517
atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML [Phenohytro]SBDC · CureCurrent ID 68590
atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Phenohytro]SBD · CureCurrent ID 67251
Advertisement
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.